Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitization to kidney transplants.

G W Rankin, X M Wang, P I Terasaki

    Clinical Transplants
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Kidney transplant recipients with high levels of panel reactive antibodies (PRA) have lower graft survival. Sensitization from pregnancy or graft failure significantly impacts survival, while transfusions have a weaker effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus.

    Journal of virology·2000
    Same author

    Absence of detectable human herpesvirus 8 in the semen of human immunodeficiency virus-infected men without Kaposi's sarcoma.

    The Journal of infectious diseases·1997
    Same author

    Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species.

    Journal of virology·1997
    Same author

    A new microcellular cytotoxicity test based on calcein AM release.

    Human immunology·1993
    Same author

    Landsteiner Award. HLA epitope matching.

    Transfusion·1992
    Same author

    HLA matching effect on five-year graft survival and half-life in the cyclosporine era.

    Kidney international. Supplement·1992

    Area of Science:

    • Nephrology and Immunology
    • Transplantation Science

    Background:

    • Kidney graft survival is significantly impacted by pre-transplant sensitization, particularly in first-time recipients with high panel reactive antibodies (PRA).
    • The mechanisms behind decreased graft survival in second and multiple kidney graft recipients are not fully understood but may involve cellular immunity or undetected antibodies, such as antiplatelet antibodies.

    Purpose of the Study:

    • To analyze the impact of pre-transplant sensitization on kidney graft survival rates across different recipient groups.
    • To investigate the relative contribution of various sensitization stimuli, including transfusions, pregnancy, and graft failure.
    • To evaluate the effectiveness of T-cell flow cytometry crossmatch (FCXM) in improving graft survival for multiple graft recipients.

    Main Methods:

    • Analysis of graft survival rates in kidney transplant recipients stratified by PRA levels (nonsensitized, moderately sensitized, highly sensitized).

    Related Experiment Videos

  • Comparison of graft survival in first-time versus second and multiple graft recipients.
  • Evaluation of the impact of transfusions, pregnancy, and graft failure on sensitization and subsequent graft survival.
  • Assessment of changes in graft survival rates for multiple graft recipients following the prospective use of T-cell FCXM.
  • Main Results:

    • Highly sensitized (greater than 50% PRA) first kidney graft recipients exhibit significantly lower graft survival rates compared to nonsensitized and moderately sensitized recipients.
    • The detrimental effect of sensitization is most pronounced within the first month post-transplantation.
    • Pregnancy and graft failure are stronger stimuli for sensitization than transfusions; however, low numbers of transfusions may benefit second kidney graft survival.
    • While T-cell FCXM has improved graft survival for multiple graft recipients, sensitized multiple transplant recipients still have lower survival rates than their nonsensitized counterparts.

    Conclusions:

    • High levels of pre-transplant sensitization are a critical negative predictor of kidney graft survival, especially in the early post-transplant period.
    • Understanding and mitigating the effects of sensitization, including identifying novel antibody targets, is crucial for improving outcomes in multiple graft recipients.
    • While T-cell FCXM is beneficial, further strategies are needed to enhance graft survival in sensitized patients undergoing re-transplantation.